Læknaneminn - 01.04.1997, Side 52

12. Ohto H, Terazwa S, Sasaki N o.fl. Transmission of hepatitis C virus
from mothers to infants. The Vertical Transmission of Hepatitis C
Virus Collaborative Study Group. N Engl J Med. 1994; 330: 744-
750.
13. Sanchez-Quijano A Rey C, Aguado I o.fl. Hepatitis C virus infect-
ion in sexually promiscuous groups. Eur J Clin Microbiol Infect
Dis. 1990; 9: 610-612.
14. Wright T, Hsu H, Donegan E o.fl. Hepatitis C virus not found in
fulminant non-A, non-B hepatitis. Ann Int Med. 1991; 115: 111-
112.
15. Berenguer M, Wright TL. Hepatitis C virus. Advances in
Gastroenterology, Hepatology & Clinical Nutrition. 1996; 1: 2-21.
16. Seef LB, Buskell-Bales Z, Wright EC o.fl. Long-term mortality aft-
er transfusion-associated non-A, non-B hepatitis. The National He-
art, Lung, and Blood Institute Study Group. N Engl J Med. 1992;
27: 1906-1911.
17. Di Bisceglie AM, Goodman ZD, Ishak KG o.fl. Long-term clinical
and histopathological follow-up of chronic post-transfusion hepatit-
is. Hepatology 1991; 14: 969-974.
18. Tong MJ, el-Farra NS, Reikes AR o.fl. Clinical outcome after trans-
fusion-associated hepatitis C. N Engl J Med. 1995; 332: 1463-
1466.
19. Koretz RL, Abbey H, Coleman E o.fl. Non-A, non-B post-trans-
fusion hepatitis: Looking back in the second decade. Ann Intern
Med. 1993; 119: 110-115.
20. Bruix J, Barrera JM, Calvet X o.fl. Prevalence of antibodies to hepa-
titis C virus in Spanish patients with hepatocellular carcinoma and
hepatic cirrhosis. Lancet 1989; ii: 1004-1006.
21. Tsukma H, Hiyama T, Tanaka S o.fl. Risk factors for hepatocellular
carcinoma among patients with chronic liver disease. N Engl J Med.
1993; 328: 1797-1801.
22. DeCastro M, Sanchez J, Herrera JF o.fl. Hepatitis C virus antibod-
ies and liver disease in patients with porphyria cutanea tarda.
Hepatology 1993; 17: 551-557.
23. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus in-
fection in type II cryoglobulinemia. N Engl J Med. 1992; 327:
1490-1495.
24. Haddad J, Dény P, Munz-Gotheil C o.fl. Lymphocytic sialoadenitis
of Sjögren's syndrome associated with chronic hepatitis C virus liver
disease. Lancet 1992; 339: 321-323.
25. Nakagiri I, Ichihara K, Ohmoto K. Analysis of discordant test results
among five second generation assays for anti-hepatitis C virus anti-
bodies also tested by polymerase chain reaction-RNA assay and
other laboratory and clinical tests for hepatitis. J Clin Microbiol.
1993; 31: 297402980.
26. Young KK, Resnik RM, Myers TW. Detection of hepatitis C virus
RNA by a combined reverse transcription-polymerase chain react-
ion assay. J Clin Microbiol. 1993; 31: 882-886.
27. Peters M. Mechanism of action of interferons. Semin Liver Dis.
1989; 9: 235-239.
28. Davis GL, Balart LA, Schiff ER o.fl. Treatment of chronic hepatitis
C with recombinant interferon alfa. A multicenter randomized,
controlled trial. Hepatitis Interventional Study Group. N Engl J
Med. 1989; 321: 1501-1506.
29. Di Bisceglie AM, Martin P, Kassianides C o.fl. Recombinant inter-
feron alfa therapy for chronic hepatitis C. A randomized, double
blind, placebo-controlled trial. N Engl J Med. 1989; 321: 1506-
1510.
30. Hoofnagle JH, Bisceglie AM. The treatment of chronic viral hepatit-
is. N Engl J Med. 1997;336: 347-356.
31. Di Bisceglie A, Conjeevaram Hm Fried M o.fl. Ribavirin as therapy
for chronic hepatitis C: a randomized, double-blind, placebo-con-
trolled trial. Ann Intern Med. 1995; 123: 897-903.
32. Reichard O, Norkrans G, Fryden A o.fl. Alfa-interferon and ribavirin
versus alfa-interferon alone as therapy for chronic hepatitis C: a ran-
domized, double-blind, placebo-controlled study. Hepatology 1996;
24: 356A
33. Schvarez R, Ando Y, Sönnerborg A o.fl. Combination treatment
with interferon alfa-2b and ribavirin for chronic hepatitis C in pati-
ents who have failed to achieve sustained response to interferon
alone: Swedish experience. J Hepatol 1995; 23(suppl 2): 17-21.
34. Asher NL, Lake JR, Emond J o.fl. Liver transplantation for hepatit-
is C virus-related cirrhosis. Hepatology 1994; 20 (1 Pt 2):24S-27S.
35. Feray C, Gigou M, Samuel D o.fl. The course of hepatitis C virus
infection after liver transplantation. Hepatology 1994; 20: 1137-
1143.
LÆKNANEMINN
50
1. tbl. 1997, 50. árg.